PATENT CLAIM ANALYSIS

Application Number: 15954964
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "788000"]

Abstract:
The present invention relates to compounds of formula I wherein R 1′  is methyl; R 1  is methyl, ethyl, CF 3 , CH 2 OH, cyclopropyl or cyano, or      R 1′  and R 1  may form together a 1,1-dioxo-tetrahydro-thiophen-3-yl ring;       R 2  is hydrogen, methyl, ethyl, isopropyl, tert-butyl, cyclopropyl, cyclopropylmethyl, or hydroxmethyl; R 3  is Cl, F, CF 3 , methyl, methoxy, or cyclopropyl; R 4  is hydrogen, methyl, F or Cl; X is N or CH; Y is N or CH;      with the proviso that X and Y are not simultaneously CH; or to a pharmaceutically acceptable salt or acid addition salt, to a racemic mixture, or to its corresponding enantiomer and/or optical isomer and/or stereoisomer.  The compounds of formula I may be used in the treatment of psychiatric disorders such as schizophrenia, bipolar disorder, obsessive-compulsive disorder or autism spectrum disorder.

Claim (Index 9):
A pharmaceutical composition comprising a compound of formula I as claimed in  claim 1 , or a pharmaceutically acceptable salt thereof, and one or more pharmaceutically acceptable excipients.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 2.1358
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15938587', '15830399', '15866444', '15891922', '15569349']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8035597759643033
- 35 USC 102 Novelty (BERT): 0.6117060711795599
- Combined Prediction Score: 0.7843744054858289
- Mean Citation Score: 504.439934
- Max Citation Score: 533.1709599999998
- Similarity Product: 508.2032003358982

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test